Last reviewed · How we verify
NCT04343508
Impact of Fortified Rice on Workers' Nutrition Status
NA trial testing Fortified rice in Nutrient Deficiency in 133 participants. Completed in 30 September 2018.
30 September 2018
Quick facts
| Lead sponsor | dsm-firmenich Switzerland AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 133 |
| Start date | 11 March 2018 |
| Primary completion | 30 September 2018 |
| Estimated completion | 30 September 2018 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Fortified rice
Conditions studied
- Nutrient Deficiency — all drugs for Nutrient Deficiency →
Sponsor
dsm-firmenich Switzerland AG — full company profile →
Who can join
Adults 20 to 50, male only, with Nutrient Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a single center, open label, nutrition intervention study. Healthy adult male working at a Singapore construction site are included if they fulfill inclusion and exclusion criteria. Volunteers receive fortified rice for their daily lunch and dinner each day of the week (i e 14 meals/week) over six months. Nutrition status in blood is measured at baseline and after six months of fortified rice consumption.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Optimizing health and nutrition status of migrant construction workers consuming multiple micronutrient fortified rice in Singapore.
Hannes F, Moon K, Moench Pfanner R. · · 2023 · PMID 37262034 · DOI 10.1371/journal.pone.0285708
Verify or expand the search:
- PubMed search for NCT04343508
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nutrient Deficiency
Currently open trials in the same condition.
- NCT07271316 — Alii Supplement Study · Phase 2 · recruiting
- NCT06835738 — Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda · NA · recruiting
- NCT05608772 — Conversion to SADI-S, RYGB or OAGB After Failed Sleeve · NA · recruiting
- NCT06025786 — Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children · NA · recruiting
- NCT04288531 — Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region · active not recruiting
Other dsm-firmenich Switzerland AG trials
Trials by the same sponsor.
- NCT06889779 — Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms · NA · recruiting
- NCT06425081 — Investigating the Impact of Humiome B2 (Colon Delivered Riboflavin) and Riboflavin-overproducer Probiotic Strain Limosil · NA · completed
- NCT06578455 — A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions · Phase 1 · completed
- NCT06471023 — A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms · NA · completed
- NCT05205785 — Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS) · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04343508 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by dsm-firmenich Switzerland AG
- Last refreshed: 9 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04343508.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing